YPOG advised the consortium of investors on the deal, alongside with KNPZ. CMS advised Cardior Pharmaceuticals GmbH. Cardior Pharmaceuticals GmbH has closed a €64 million series B…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
